NirvaMed Overview

  • Founded

  • 2010

Founded
  • Status

  • Private

  • Employees

  • 5

Employees
  • Latest Deal Type

  • Series B

  • (Cancelled)
  • Investors

  • 6

NirvaMed General Information

Description

Developer of a patented breakthrough therapy intended to reduce heart muscle damage suffered by heart attack patients. The company provides treatment for massive heart attacks, its ST-Elevation Myocardial Infarction (STEMI) heart attacks through its proprietary percutaneous catheter, designed to substantially reduce heart muscle death and redefine the standard of care, enabling medical professionals to reduce health disparity in communities.

Contact Information

Website
www.nirvamed.com
Formerly Known As
Nirva Medical, Nirva Medical LLC
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Primary Office
  • 8500 Pillsbury Avenue South
  • Minneapolis, MN 55420
  • United States
+1 (952) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NirvaMed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Later Stage VC (Series B) 11-Jun-2021 Cancelled Generating Revenue
2. Later Stage VC (Series A2) 07-Sep-2019 00.000 00.000 000 Completed Generating Revenue
1. Angel (individual) 20-Apr-2015 $260K $260K Completed Generating Revenue
To view NirvaMed’s complete valuation and funding history, request access »

NirvaMed Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a patented breakthrough therapy intended to reduce heart muscle damage suffered by heart attack patients. T
Therapeutic Devices
Minneapolis, MN
5 As of 2023
00.000
00000000000

000000

adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna ali
00000000000 0000000
Mullica Hill, NJ
0000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

NirvaMed Competitors (1)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
000000000 Corporation Mullica Hill, NJ 0000000000
You’re viewing 1 of 1 competitors. Get the full list »

NirvaMed Patents

  • 17

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 2

    Granted

  • 000

    Pending

  • 000

    Expiring in next 12 mo

NirvaMed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11071845-B2 Localized therapy delivery and local organ protection Active 02-Feb-2010 00000000
EP-2531251-A1 Localized therapy delivery and local organ protection Active 02-Feb-2010 0000000000
EP-2531251-B1 Localized therapy delivery and local organ protection Active 02-Feb-2010 0000000000
EP-3620202-A1 Localized therapy delivery and local organ protection Pending 02-Feb-2010 0000000000 0
US-11173239-B2 Localized therapy delivery and local organ protection Active 02-Feb-2010 A61M1/3613 00
To view NirvaMed’s complete patent history, request access »

NirvaMed Executive Team (3)

Name Title Board Seat Contact Info
Pramote Hochareon Ph.D Founder & Chief Executive Officer
Cindy Clague Ph.D Chief Research Scientist
You’re viewing 2 of 3 executive team members. Get the full list »

NirvaMed Board Members (3)

Name Representing Role Since
Ed Shapland NirvaMed Board Member & Advisor 000 0000
Prasit Watanapa NirvaMed Board Member 000 0000
Tina Tosukhowong Ph.D GC Ventures Board Observer 000 0000
To view NirvaMed’s complete board members history, request access »

NirvaMed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NirvaMed Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bangkok Dusit Medical Services Corporation Minority 000 0000 000000 0
GC Ventures Corporate Venture Capital Minority 000 0000 000000 0
PTT Global Chemical Corporation Minority 000 0000 000000 0
Samart Corp Corporation Minority 000 0000 000000 0
SeaX Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Ready to get started?

Request a free trial